Avibactam/ceftazidimeAcquired drug resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2051卷 / 1期

关键词：

D O I：

10.1007/s40278-025-79571-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[31] Avibactam/ceftazidime/aztreonamTherapy ineffective: 2 case reports
Reactions Weekly, 2020, 1817 (1) : 71 - 71
[32] Erlotinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1753 (1) : 161 - 161
[33] Afatinib/gefitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1708 (1) : 28 - 28
[34] Ceftazidime/meropenemEmerging drug resistance: 2 case reports
Reactions Weekly, 2015, 1580 (1) : 94 - 94
[35] Multipe drugsAcquired drug resistance: 2 case reports
Reactions Weekly, 2020, 1817 (1) : 218 - 218
[36] AntibacterialsLack of efficacy and drug resistance: 2 case reports
Reactions Weekly, 2023, 1947 (1) : 49 - 49
[37] AntineoplasticsLack of efficacy and drug resistance: 2 case reports
Reactions Weekly, 2023, 1944 (1) : 84 - 84
[38] Amikacin/rifampicinAcquired drug resistance: 2 case reports
Reactions Weekly, 2018, 1730 (1) : 26 - 26
[39] Glecaprevir/pibrentasvirVomiting and drug resistance: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 185 - 185
[40] AntibacterialsRash and development of drug resistance: 2 case reports
Reactions Weekly, 2021, 1836 (1) : 71 - 71

← 1 2 3 4 5 →